Anavex life sciences to present at the 20th annual needham virtual healthcare conference

New york, april 08, 2021 (globe newswire) -- anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including alzheimer's disease, parkinson's disease, rett syndrome and other central nervous system (cns) disorders, today announced that christopher u. missling, phd, president and chief executive officer of anavex, will present at the 20th annual needham virtual healthcare conference on thursday, april 15, 2021 at 8:45 a.m. edt.
AVXL Ratings Summary
AVXL Quant Ranking